GI
REGN icon

Gradient Investments’s Regeneron Pharmaceuticals REGN Stock Holding History

Gradient Investments’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$516K Sell
827
-19
-2% -$12.9K 0.01% 369
2026
Q1 		$654K Sell
846
-50
-6% -$38.3K 0.01% 331
2025
Q4 		$692K Buy
+896
New +$608K 0.01% 265
2024
Q3 		– Sell
-9
Closed -$9.46K – 1045
2024
Q2 		$9.46K Sell
9
-1
-10% -$969 ﹤0.01% 748
2024
Q1 		$9.63K Sell
10
-6
-38% -$5.71K ﹤0.01% 644
2023
Q4 		$14.1K Hold
16
– – ﹤0.01% 773
2023
Q3 		$13.2K Sell
16
-1
-6% -$786 ﹤0.01% 754
2023
Q2 		$12.2K Buy
17
+4
+31% +$3.08K ﹤0.01% 778
2023
Q1 		$10.7K Sell
13
-1
-7% -$754 ﹤0.01% 799
2022
Q4 		$10.1K Hold
14
– – ﹤0.01% 808
2022
Q3 		$10K Hold
14
– – ﹤0.01% 809
2022
Q2 		$8K Buy
14
+3
+27% +$1.95K ﹤0.01% 826
2022
Q1 		$8K Hold
11
– – ﹤0.01% 827
2021
Q4 		$7K Hold
11
– – ﹤0.01% 878
2021
Q3 		$7K Hold
11
– – ﹤0.01% 839
2021
Q2 		$6K Hold
11
– – ﹤0.01% 854
2021
Q1 		$5K Sell
11
-1
-8% -$487 ﹤0.01% 892
2020
Q4 		$7K Hold
12
– – ﹤0.01% 761
2020
Q3 		$7K Buy
12
+5
+71% +$3.03K ﹤0.01% 768
2020
Q2 		$4K Buy
7
+1
+17% +$568 ﹤0.01% 791
2020
Q1 		$3K Hold
6
– – ﹤0.01% 870
2019
Q4 		$2K Buy
6
+2
+50% +$673 ﹤0.01% 954
2019
Q3 		$1K Buy
+4
New +$1.18K ﹤0.01% 1037
2018
Q2 		– Sell
-1
Closed – – 1111
2018
Q1 		$0 Sell
1
-3
-75% -$1.04K ﹤0.01% 1130
2017
Q4 		$2K Buy
+4
New +$1.62K ﹤0.01% 827
2015
Q3 		– Sell
-30
Closed -$15K – 668
2015
Q2 		$15K Buy
+30
New +$14.6K ﹤0.01% 337
2013
Q4 		– Sell
-2
Closed -$1K – 645
2013
Q3 		$1K Sell
2
-387
-99% -$102K ﹤0.01% 456
2013
Q2 		$87K Buy
+389
New +$90.6K 0.03% 153

Other funds holding REGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Gradient Investments's REGN Position: Q2 2026 in Review

Gradient Investments reduced its Regeneron Pharmaceuticals (REGN) stake by 2.2% in Q2 2026, selling an estimated $12.9K and leaving 827 shares worth $516K. The position accounts for 0.01% of the portfolio, ranked #369.

Gradient Investments first reported a position in REGN in Q2 2013 and has held it in 28 quarters since. The position peaked at $692K in Q4 2025. 1,332 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

  • Gradient Investments held 827 shares of Regeneron Pharmaceuticals worth $516K as of Q2 2026.
  • Gradient Investments sold 19 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $12.9K.
  • Regeneron Pharmaceuticals made up 0.01% of Gradient Investments's portfolio in Q2 2026, its #369 holding.
  • Gradient Investments first reported a position in Regeneron Pharmaceuticals in Q2 2013 and has held it in 28 quarters since.
  • Gradient Investments's Regeneron Pharmaceuticals position peaked at $692K in Q4 2025.
  • 1,332 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on Gradient Investments's 13F filing for Q2 2026, filed 8 Jul 2026.